DIAGNOSIS AND TREATMENT OF HEPATOCELLULAR CARCINOMA WITH PELVIC METASTASIS EXPRESSING AFP: A CASE REPORT

Diagnosis and treatment of hepatocellular carcinoma with pelvic metastasis expressing AFP: a case report

Diagnosis and treatment of hepatocellular carcinoma with pelvic metastasis expressing AFP: a case report

Blog Article

This report presents the case of a 68-year-old female patient with hepatocellular carcinoma (HCC) who experienced persistently elevated alpha-fetoprotein (AFP) levels following resection of the primary liver tumor.The patient had previously undergone transcatheter arterial chemoembolization (TACE) and liver SUNFLOW VIT E tumor resection, but postoperative AFP levels continued to rise, suggesting the possibility of extrahepatic metastasis.PET-CT scans revealed an irregular soft tissue mass in the recto-uterine pouch, which was later confirmed as a HCC metastasis through needle biopsy.The patient subsequently received radioactive seed implantation therapy, leading to a significant decrease in AFP levels.This case highlights the rarity of isolated pelvic metastasis in HCC patients and underscores the importance of AFP in postoperative monitoring.

The combination of PET-CT imaging and pathological biopsy is instrumental in improving the detection rate of HCC metastases, enabling more accurate treatment planning iPad Case for patients.

Report this page